|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,401.00 GBX | +0.79% |
|
-0.50% | -17.64% |
| 12-02 | Blue-chips start "pivotal" week on the front foot | AN |
| 12-02 | JPMorgan Upgrades Johnson Matthey to Neutral | MT |
| Capitalization | 2.37B 3.02B 2.88B 2.67B 4.28B 257B 4.75B 33.21B 12.26B 105B 11.35B 11.11B 460B | P/E ratio 2025 * |
9.28x | P/E ratio 2026 * | 8.16x |
|---|---|---|---|---|---|
| Enterprise value | 3.2B 4.07B 3.88B 3.59B 5.77B 346B 6.39B 44.73B 16.51B 142B 15.29B 14.96B 619B | EV / Sales 2025 * |
0.89x | EV / Sales 2026 * | 0.9x |
| Free-Float |
94.06% | Yield 2025 * |
5.52% | Yield 2026 * | 5.6% |
More valuation ratios
* Estimated data
More news
Last Transcript: Johnson Matthey Plc
More recommendations
More press releases
More news
| 1 day | -0.04% | ||
| 1 week | -1.40% | ||
| Current month | +1.94% | ||
| 1 month | -9.33% | ||
| 3 months | -11.76% | ||
| 6 months | -14.43% | ||
| Current year | -18.39% |
1 week
1 372.00
1 432.00
1 month
1 318.001 531.00
Current year
1 318.001 917.07
1 year
1 318.001 917.07
3 years
1 318.002 536.00
5 years
1 318.003 363.00
10 years
1 318.003 873.00
| Director | Title | Age | Since |
|---|---|---|---|
Liam Condon
CEO | Chief Executive Officer | 56 | 28/02/2022 |
Stephen Oxley
DFI | Director of Finance/CFO | - | 31/03/2021 |
Liz Rowsell
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2023 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jane Griffiths
BRD | Director/Board Member | 69 | 31/12/2016 |
John O'Higgins
BRD | Director/Board Member | 59 | 15/11/2017 |
Patrick Thomas
CHM | Chairman | 67 | 25/07/2018 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.75% | 7 M€ | +0.11% | - | |
| 0.22% | 177 M€ | +10.07% | ||
| 0.17% | 11 M€ | +0.83% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.04% | -1.40% | -14.88% | -30.71% | 3.02B | ||
| -0.94% | -0.45% | +28.59% | +6.48% | 69.96B | ||
| -0.61% | -2.63% | -7.46% | -38.88% | 41.94B | ||
| +0.42% | +2.12% | +16.50% | -16.47% | 41.55B | ||
| +1.00% | +0.26% | +17.51% | +20.67% | 26.87B | ||
| -0.55% | +0.80% | -4.70% | -33.09% | 16.75B | ||
| +0.97% | +0.58% | -1.47% | -20.28% | 15.13B | ||
| -5.18% | -4.67% | -18.76% | -60.44% | 12.22B | ||
| -0.82% | +2.27% | -22.15% | -30.38% | 11.44B | ||
| -0.04% | +2.55% | +22.07% | +43.89% | 11.41B | ||
| Average | -0.56% | -0.08% | +1.53% | -15.92% | 25.03B | |
| Weighted average by Cap. | -0.44% | -0.32% | +9.85% | -11.37% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.58B 4.57B 4.35B 4.03B 6.47B 387B 7.17B 50.14B 18.51B 159B 17.14B 16.77B 694B | 3.56B 4.54B 4.32B 4.01B 6.43B 385B 7.13B 49.89B 18.42B 158B 17.05B 16.69B 691B |
| Net income | 258M 329M 313M 290M 466M 27.95B 517M 3.62B 1.34B 11.48B 1.24B 1.21B 50.08B | 276M 351M 335M 310M 498M 29.83B 552M 3.86B 1.43B 12.25B 1.32B 1.29B 53.45B |
| Net Debt | 823M 1.05B 998M 925M 1.49B 89.01B 1.65B 11.52B 4.25B 36.55B 3.94B 3.85B 160B | 826M 1.05B 1B 929M 1.49B 89.34B 1.65B 11.56B 4.27B 36.68B 3.95B 3.87B 160B |
More financial data
* Estimated data
Employees
11,685
Sector
Specialty Chemicals
Calendar
21/05/2025
- Q4 2025 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/12/24 | 1,398.00 p | +0.58% | 100,475 |
| 10/12/24 | 1,390.00 p | -1.28% | 569,864 |
| 09/12/24 | 1,408.00 p | +1.51% | 970,451 |
| 06/12/24 | 1,387.00 p | +0.07% | 662,233 |
| 05/12/24 | 1,386.00 p | -1.35% | 710,006 |
Delayed Quote London S.E., December 11, 2024 at 09:35 am
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
13.90GBP
Average target price
17.62GBP
Spread / Average Target
+26.78%
Annual profits - Rate of surprise
- Stock Market
- Equities
- JMAT Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition